loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 203013 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 BUPROPION HYDROCHLORIDE (2)

filter

01 ALEMBIC (2)

filter

01 TABLET;ORAL (2)

filter

01 100MG (1)

02 75MG (1)

filter

01 USA (2)

URL Supplier Web Content
TABLET;ORAL
100MG
BUPROPION HYDROCHLORID...
USA
203013
2018-06-08
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
75MG
BUPROPION HYDROCHLORID...
USA
203013
2018-06-08
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 203013

Looking for CTD TGA MCC DOSSIER APPLICATION 203013 2

19

Alembic Pharmaceuticals Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is BUPROPION HYDROCHLORIDE, with a corresponding application number 203013 and regulatory information .

proudly manufactured in the

approval since 2018-06-08

Alembic Pharmaceuticals Limited's BUPROPION HYDROCHLORIDE TABLET;ORAL, medication with 100MG of BUPROPION HYDROCHLORIDE.

18

Alembic Pharmaceuticals Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is BUPROPION HYDROCHLORIDE, with a corresponding application number 203013 and regulatory information .

proudly manufactured in the

approval since 2018-06-08

Alembic Pharmaceuticals Limited's BUPROPION HYDROCHLORIDE TABLET;ORAL, medication with 75MG of BUPROPION HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY